We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




CC Imaging Capsule Requires No Colon Preparation

By MedImaging International staff writers
Posted on 14 Jan 2020
Print article
Image: The Check-Cap prepless disposable capsule (Photo courtesy of Check-Cap)
Image: The Check-Cap prepless disposable capsule (Photo courtesy of Check-Cap)
A new preparation-free ingestible scanning capsule helps prevent colorectal cancer (CC) through the detection of precancerous polyps.

The Check-Cap (Isfiya, Israel) C-Scan System is comprised of an ultra-low dose X-ray capsule, an integrated positioning, control, and recording system, and proprietary software that is used to generate a three dimensional (3D) map of the inner lining of the colon. The heart of the system is the C-Scan Cap, an ingestible imaging capsule consisting of X-ray source that is collimated and rotated, forming three beams that scan the colon from within. Radiofrequency (RF) communication transmits the data to C-Scan Track, a tracking control and data collection unit comprised of three external patches that are worn on the patient's back.

C-Scan Track consists of an integrated positioning, control, and recording system that continuously tracks the capsule’s position and orientation along the colon, activates the capsule's scanning function during movement in the colon, and records and stores the capsule's information for future download. As the patient continues normal daily activities, the capsule is propelled through the gastrointestinal tract by natural motility, while continuously measuring the internal circumferential dimensions and tracking the position and orientation of the capsule within the body. The information is later used by C-Scan View to construct 2D and 3D images of the colon surface.

Patients swallow the capsule together with one tablespoon of radiopaque contrast solution; no fasting or bowel preparation is required. When C-Scan Cap has completed its passage, it is naturally excreted from the patient's body. The X-ray dose to which patients are exposed to for the entire procedure, from ingestion to excretion of the capsule, is similar to that of a single chest radiograph, significantly lower than conventional medical imaging procedures using X-rays such as computed tomography (CT) of the abdomen and pelvis and screening mammography.

“Check-Cap's prep-free, non-invasive technology meets the real need for colon cancer screening that's easy for patients. Patients are often hesitant to undergo colonoscopy due to the preparation, sedation, general discomfort and potential risks,” said Professor Oscar Lebwohl, MD, of Columbia University (New York, NY, USA). “If further studies demonstrate that Check-Cap is an accurate screening modality for colon cancer and polyps, then the Check-Cap system will be a viable testing alternative, allowing the screening of patients in greater numbers and the use of fewer resources compared with CTC and Colonoscopy.”

Related Links:
Check-Cap

NMUS & MSK Ultrasound
InVisus Pro
Digital Radiographic System
OMNERA 300M
Multi-Use Ultrasound Table
Clinton
New
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices

Print article

Channels

MRI

view channel
Image: An AI tool has shown tremendous promise for predicting relapse of pediatric brain cancer (Photo courtesy of 123RF)

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans

Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.